Immune Deficiency Foundation

IVIG therapy patient advocates unite to pursue Medicare reform

Published in Lab Law Weekly, October 21st, 2005

To prevent patients from losing complete access to their life-sustaining IVIG (intravenous immune globulin) therapy, the community's advocacy organizations, physicians who treat these patients, manufacturers, distributors, hospitals, and others, have achieved consensus on a proposal to reform reimbursement for IVIG.

The current IVIG access issue began in January 2005 as a result of the Medicare Modernization Act under Part B. The law reduced IVIG reimbursement and administration rates such that most physicians in outpatient settings can no longer afford to treat Medicare patients requiring IVIG. With the proposed Hospital Outpatient Prospective Payment System (HOPPS)...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2005-10-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry